RNY3 pseudogene 8 (RNY3P8)

RNY3 pseudogene 8 is a human genomic element classified as a pseudogene related to RNY3 (Ro60-associated Y3 RNA), a member of the non-coding Y-RNA family. RNY3 is expressed and may play roles in RNA quality control, non-coding RNA folding, and possibly modulate cellular proliferation and cytokine expression, but RNY3P8 itself is a nonfunctional duplicate and is not expressed as a protein or known to have RNA-level functions[6]. Over 1000 such pseudogenes exist in the human genome as a result of reverse transposition; while some pseudogenes may be transcribed or even have regulatory effects, there is currently no evidence for biological function, disease association, or therapeutic relevance specific to RNY3P8[1][4][6]. Key context and assessment: - Not a canonical target: RNY3P8 is a pseudogene, not a protein, non-coding RNA, enzyme, receptor, transporter, or other conventional therapeutic target[6]. - No known function or druggability: There is currently no evidence RNY3P8 produces a functional RNA or has any effect in cells or disease[6]. - Potential for confusion: Occasionally, pseudogenes or their transcribed RNAs can have regulatory functions or be implicated in disease as competitive endogenous RNAs[2]. However, for RNY3P8, no such activity is described or supported in the literature. - Is this a valid target?: The gene name refers specifically to a pseudogene, not to the active Y-RNA gene (RNY3). For context, RNY3 itself (not the pseudogene) is a non-coding RNA that may modulate T cell activation, RNA processing, and cytokine expression[1][5]. RNY3 pseudogenes like RNY3P8 are typically considered "genomic fossils" without clear function[4][6]. Summary judgment: RNY3P8 is a nonfunctional pseudogene with no established biological or clinical role; it is not a valid therapeutic target, and using it as such is incorrect[6]. Information about the parent gene RNY3 or the Y-RNA family is distinct and should not be conflated with this pseudogene.

Not applicable; there are no known drugs or interventions targeting this pseudogene